141 related articles for article (PubMed ID: 25942021)
1. Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.
Lewandowski D; Lewandowska M; Ruszkowski P; Pińska A; Schroeder G
PLoS One; 2015; 10(5):e0126251. PubMed ID: 25942021
[TBL] [Abstract][Full Text] [Related]
2. SBA-15 Mesoporous Silica Modified with Gallic Acid and Evaluation of Its Cytotoxic Activity.
Lewandowski D; Ruszkowski P; Pińska A; Schroeder G; Kurczewska J
PLoS One; 2015; 10(7):e0132541. PubMed ID: 26151908
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph
Bensing C; Mojić M; Gómez-Ruiz S; Carralero S; Dojčinović B; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
Dalton Trans; 2016 Dec; 45(47):18984-18993. PubMed ID: 27847952
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin.
Alvarez-Berríos MP; Vivero-Escoto JL
Int J Nanomedicine; 2016; 11():6251-6265. PubMed ID: 27920531
[TBL] [Abstract][Full Text] [Related]
5. Novel Antitumor Agents Based on Fluorescent Benzofurazan Derivatives and Mesoporous Silica.
Tudose M; Culita DC; Baratoiu-Carpen RD; Mitran RA; Kuncser A; Romanitan C; Popescu RC; Savu DI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555305
[TBL] [Abstract][Full Text] [Related]
6. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
7. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
8. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional mesoporous hollow silica nanocapsules for targeted co-delivery of cisplatin-pemetrexed and MR imaging.
Mohapatra S; Rout SR; Narayan R; Maiti TK
Dalton Trans; 2014 Nov; 43(42):15841-50. PubMed ID: 25224136
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the mechanism of apoptosis in cancer cell lines by treatment with silica-based nanostructured materials functionalized with different metallodrugs.
Díaz-García D; Cenariu D; Pérez Y; Cruz P; Del Hierro I; Prashar S; Fischer-Fodor E; Gómez-Ruiz S
Dalton Trans; 2018 Sep; 47(35):12284-12299. PubMed ID: 30112529
[TBL] [Abstract][Full Text] [Related]
11. The interaction between SBA-15 derivative loaded with Ph
Maksimović-Ivanić D; Bulatović M; Edeler D; Bensing C; Golić I; Korać A; Kaluđerović GN; Mijatović S
J Biol Inorg Chem; 2019 Mar; 24(2):223-234. PubMed ID: 30759278
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Gemcitabine Prodrugs Employing Mesoporous Silica Nanoparticles.
Malfanti A; Miletto I; Bottinelli E; Zonari D; Blandino G; Berlier G; Arpicco S
Molecules; 2016 Apr; 21(4):522. PubMed ID: 27110750
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine Glycosylation by Filamentous Fungi Leads to a Better Redox Stability and Improved Cytotoxicity in B16F10 Murine Melanoma Cells.
Arruda EL; Japiassu KB; de Melo Souza PL; Araújo KCF; Thomaz DV; Cortez AP; Garcia LF; Valadares MC; de Souza Gil E; de Oliveira V
Anticancer Agents Med Chem; 2020; 20(14):1688-1694. PubMed ID: 32329702
[TBL] [Abstract][Full Text] [Related]
14. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
15. Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery.
Pang J; Zhao L; Zhang L; Li Z; Luan Y
J Colloid Interface Sci; 2013 Apr; 395():31-9. PubMed ID: 23312579
[TBL] [Abstract][Full Text] [Related]
16. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
[TBL] [Abstract][Full Text] [Related]
18. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
Tao Z; Toms B; Goodisman J; Asefa T
ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma.
Nejabat M; Mohammadi M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Carbohydr Polym; 2018 Oct; 197():157-166. PubMed ID: 30007600
[TBL] [Abstract][Full Text] [Related]
20. Core-Shell-structured Dendritic Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Antibody Delivery.
Abbaraju PL; Yang Y; Yu M; Fu J; Xu C; Yu C
Chem Asian J; 2017 Jul; 12(13):1465-1469. PubMed ID: 28481442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]